Release factor 3 degradation enhances aminoglycoside-mediated translational readthrough at MECP2 nonsense mutations

Dennis Lebeda, Daniela Smoljanow, Julia Hofhuis, Sven Thoms

Open source

DOI
10.1007/s00109-026-02728-z
Published
2026-10-22
Container
Journal of Molecular Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00109-026-02728-z,
  title = {Release factor 3 degradation enhances aminoglycoside-mediated translational readthrough at MECP2 nonsense mutations},
  author = {Dennis Lebeda and Daniela Smoljanow and Julia Hofhuis and Sven Thoms},
  year = {2026},
  journal = {Journal of Molecular Medicine},
  doi = {10.1007/s00109-026-02728-z},
  url = {https://doi.org/10.1007/s00109-026-02728-z}
}

RIS

TY  - JOUR
TI  - Release factor 3 degradation enhances aminoglycoside-mediated translational readthrough at MECP2 nonsense mutations
AU  - Dennis Lebeda
AU  - Daniela Smoljanow
AU  - Julia Hofhuis
AU  - Sven Thoms
PY  - 2026
JO  - Journal of Molecular Medicine
DO  - 10.1007/s00109-026-02728-z
UR  - https://doi.org/10.1007/s00109-026-02728-z
ER  - 

APA

Lebeda, D., Smoljanow, D., Hofhuis, J., & Thoms, S. (2026). Release factor 3 degradation enhances aminoglycoside-mediated translational readthrough at MECP2 nonsense mutations. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-026-02728-z

Source records